ClaimsFiler reminds ADMA Biologics investors of the August 10 lead‑plaintiff deadline in a securities class action lawsuit
Executive summary: ClaimsFiler issued a shareholder alert reminding ADMA Biologics investors with losses exceeding $100,000 that the deadline to file lead plaintiff applications in the ongoing class action lawsuit is August 10, 2026. The deadline determines who can steer the litigation, potentially influencing settlement negotiations, legal costs, and the stock’s near‑term volatility.
Who is involved: ADMA Biologics (Nasdaq: ADMA), ClaimsFiler, plaintiffs’ law firms, and shareholders who have incurred losses over $100,000.
Likely next: Investors must submit lead plaintiff applications by August 10; after that date the court will select a lead plaintiff and the case will proceed to pre‑trial motions.
ClaimsFiler’s notice to ADMA Biologics shareholders highlights that investors who have incurred losses exceeding $100,000 have until August 10, 2026 to seek appointment as lead plaintiff in the pending federal securities class action against the company. The reminder follows a series of similar notices issued by ClaimsFiler for other publicly traded firms, indicating that the service is actively monitoring potential class‑action deadlines across a range of sectors. The opportunity to serve as lead plaintiff allows a shareholder to shape the direction of the litigation, influence settlement negotiations, and potentially recover a larger portion of any awarded damages. While the appointment of a lead plaintiff does not guarantee a particular outcome, it can affect the pace and cost of the case for ADMA Biologics and may draw additional attention from market participants monitoring litigation risk. In the near term, the court will consider any lead‑plaintiff motions filed before the deadline, after which the case will proceed to the next procedural stage, possibly prompting short‑term volatility in ADMA’s stock as investors assess the evolving legal landscape.
Timeline
- — ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA (PR Newswire)
- — PicS Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PicS N.V. - PICS (PR Newswire)
- — Zillow Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Zillow Group, Inc. - ZG, Z (PR Newswire)
- — Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Erasca - ERAS (PR Newswire)
- — ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS (PR Newswire)
Analysis — what this means
Likely next events
- Lead plaintiff filing deadline: August 10, 2026
- Court to appoint lead plaintiff shortly after the deadline
Sectors affected
- Biotechnology
- Biologics
- Healthcare
Regulatory implications
- SEC scrutiny under §10(b) of the Securities Exchange Act of 1934
- Increased disclosure obligations for biotech firms facing shareholder lawsuits
Historical parallels
- 2021 Biogen securities class action over alleged misrepresentations
- 2018 Valeant Pharmaceuticals lawsuit related to channel‑stuffing allegations
Key entities
Sources
- ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA — PR Newswire
- PicS Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PicS N.V. - PICS — PR Newswire
- Zillow Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Zillow Group, Inc. - ZG, Z — PR Newswire
- Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Erasca - ERAS — PR Newswire
- ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA — PR Newswire
- ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS — PR Newswire
Open the full interactive case file on Beyond →
INTELLIGENCE
Social Pulse
AI estimate · not scraped